To attempt to obtain a more accurate assessment of the effects of ocular hypertension with or without SP600125 on RGC survival, retina flatmounts from treated eyes were immunolabeled with antibody to Brn-3a, a specific marker for RGCs [21]. The gene discussed is POU4F1; the disease is ocular hypertension.